The price of tirzepatide depends on what product is prescribed, which pharmacy dispenses it, whether a health plan contributes, and what clinical services are billed separately. A single search-result number rarely answers all of those questions.
This page is general information, not medical advice. Talk to a licensed clinician about your situation.
This site is an informational and pricing overview. It takes no payment, collects no protected health information, and runs no intake form. All checkout and intake happens on joinbodygood.com/intake.
Identify the exact charge
Ask who is billing and what the amount covers. A pharmacy charge is for the prescribed medication. A clinical service fee pays for the program described by the care provider. Laboratory work, supplies, or shipping may be separate.
Also ask what time period the quote covers. One-time, monthly, and multi-month amounts should not be compared without converting them to the same period and checking what services are included. Confirm the date of the quote because pharmacy prices and program terms can change.
If insurance is involved, the plan may apply a formulary, deductible, copay, coinsurance, quantity limit, or prior authorization. The plan decides approval and payment. Coverage support can help with information and paperwork, but it cannot promise the outcome.
FDA-approved prescription products
Tirzepatide is the active ingredient in Mounjaro and Zepbound, two distinct FDA-approved prescription products from Eli Lilly and Company. They have different approved uses and labeling. A licensed clinician determines whether a product is appropriate for an individual patient.
Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. They are included in the safety summary because this page later distinguishes compounded medication from all four branded products.
Important safety information: Mounjaro, Zepbound, Ozempic, and Wegovy carry boxed warnings about the risk of thyroid C-cell tumors. They are contraindicated in people with a personal or family history of medullary thyroid carcinoma, or MTC, and in people with Multiple Endocrine Neoplasia syndrome type 2, or MEN 2. Major risks described across their official Prescribing Information and Medication Guides include pancreatitis, gallbladder problems, low blood sugar when used with certain diabetes medicines, serious allergic reactions, acute kidney injury related to dehydration, and severe gastrointestinal reactions. Some labels include additional risks, including diabetic retinopathy complications. Common side effects can include nausea, diarrhea, vomiting, constipation, and abdominal pain. Read each linked manufacturer document for complete approved uses, boxed warnings, contraindications, other risks, side effects, and patient instructions.
For a current estimate, ask the dispensing pharmacy about the exact prescription. If using insurance, ask the plan and pharmacy how current benefits apply. Manufacturer savings resources have specific terms and eligibility conditions. No service should promise that a particular savings amount or coverage decision applies.
Compounded prescription products
Compounded tirzepatide is a separate category from the FDA-approved products above.
Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or manufacturing quality.
Compounded tirzepatide is not Zepbound, Mounjaro, Ozempic, or Wegovy. It is not a generic or interchangeable version of any approved drug. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S.
Compounded medications may be dispensed only pursuant to a valid prescription issued by a licensed clinician after a clinical evaluation, from a state-licensed pharmacy. The clinician decides whether any prescription is appropriate. The pharmacy should identify the product, label it clearly, provide handling instructions, and offer access to a pharmacist.
FDA explains this category in its overview of human drug compounding. A quote for a compounded prescription should identify the pharmacy and what its charge includes. It should not be treated as a price quote for an approved product.
Body Good's fee is for clinical service
Body Good's prices are Body Good service fees for the clinical program described during intake. They are not medication prices and are not a quote for any individual. Medication cost is separate and is not included. Eligibility is determined by a clinician.
The program may include clinical evaluation and follow-up described during intake. If a service includes coverage support, that support is assistance with benefits information and plan-requested paperwork. Approval and payment are determined by the plan, not by Body Good.
The dispensing pharmacy sets its medication charge. Outside laboratory services, when clinically appropriate, may create a separate charge. Keep those items on different lines when estimating the total.
How to compare estimates clearly
Use the same checklist for every estimate:
- Exact prescribed product and dosage form.
- Name and license status of the dispensing pharmacy.
- Medication quantity and period covered by the quote.
- Pharmacy charge, including any stated shipping or supplies.
- Clinical service fee and the services and period it covers.
- Separate laboratory or follow-up charges.
- Plan cost sharing or savings-program terms, if relevant.
Do not place an approved product and a compounded product in one comparison row or side-by-side columns. Describe each category separately, then compare the complete costs of care only after the product distinction is clear.
A price is not a prescribing decision
Tirzepatide is a prescription ingredient. A licensed clinician must review medical history, current medicines, allergies, and relevant risks before deciding whether to prescribe. The decision may be no, even when a patient is ready to pay.
If a prescription is issued, use only the state-licensed pharmacy involved in your care. Follow the label and the directions from the clinician and pharmacist. Do not share the prescription or change a dose on your own.
Frequently asked questions
Why do tirzepatide price estimates differ?
They may refer to different products, pharmacies, quantities, plan benefits, service fees, or dates. Ask for an itemized, current quote for the exact prescription and care program.
Is medication part of a Body Good service fee?
No. Body Good's fee is for the program described during intake. Medication cost is separate and not included. The pharmacy sets and collects its own charge.
How can I request a Body Good clinical evaluation?
Begin Body Good's secure clinical intake. Completing intake does not guarantee eligibility, a prescription, coverage, or a particular pharmacy price.
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.